Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,266 | 191 | 99.8% |
| Education | $6.97 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $557.53 | 9 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $479.50 | 44 | $0 (2019) |
| Medtronic Vascular, Inc. | $382.81 | 17 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $325.63 | 27 | $0 (2019) |
| Gilead Sciences, Inc. | $228.57 | 20 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $183.96 | 16 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $171.84 | 9 | $0 (2018) |
| ABIOMED | $149.47 | 3 | $0 (2017) |
| Roxwood Medical Inc. | $125.00 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $111.34 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $425.65 | 21 | Medtronic Vascular, Inc. ($155.61) |
| 2018 | $1,048 | 77 | Novartis Pharmaceuticals Corporation ($162.98) |
| 2017 | $1,800 | 94 | BOSTON SCIENTIFIC CORPORATION ($399.74) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/07/2019 | Abbott Laboratories | Xience Sierra Coronary Stent (Device) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 06/27/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: Cardiovascular | ||||||
| 06/18/2019 | Medtronic Vascular, Inc. | Resolute (Device) | Food and Beverage | In-kind items and services | $143.86 | General |
| Category: Stents | ||||||
| 06/18/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/06/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $14.83 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 05/13/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Hypertriglyceridemia | ||||||
| 05/12/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Diabetes | ||||||
| 05/08/2019 | Medtronic Vascular, Inc. | Resolute (Device) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Stents | ||||||
| 05/02/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/30/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/29/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/09/2019 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $15.54 | General |
| 03/28/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/21/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/19/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/13/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/25/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/25/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Hypertriglyceridemia | ||||||
| 02/07/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/15/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/20/2018 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiology | ||||||
| 12/10/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.27 | General |
| Category: Cardiovascular | ||||||
| 12/06/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $6.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/29/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 3,619 | 4,166 | $347,584 | $103,614 |
| 2022 | 15 | 3,617 | 4,239 | $392,004 | $113,758 |
| 2021 | 16 | 4,967 | 6,248 | $568,620 | $168,560 |
| 2020 | 12 | 3,058 | 3,810 | $405,420 | $138,717 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 614 | 628 | $121,593 | $33,708 | 27.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 158 | 263 | $71,936 | $25,121 | 34.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 2,200 | 2,570 | $57,337 | $16,451 | 28.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 120 | 154 | $29,228 | $9,285 | 31.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 39 | 39 | $20,711 | $5,041 | 24.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 36 | $13,016 | $3,710 | 28.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 91 | 95 | $9,798 | $3,662 | 37.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 99 | 107 | $7,267 | $2,158 | 29.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 18 | 18 | $5,070 | $1,650 | 32.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 20 | 20 | $3,842 | $1,333 | 34.7% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 78 | 84 | $1,729 | $490.56 | 28.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 19 | 19 | $1,114 | $312.12 | 28.0% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 29 | 29 | $3,458 | $263.76 | 7.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 20 | 20 | $782.20 | $217.55 | 27.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 78 | 84 | $703.92 | $211.68 | 30.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 723 | 762 | $147,538 | $41,891 | 28.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 163 | 307 | $83,971 | $25,414 | 30.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 2,002 | 2,336 | $52,116 | $14,984 | 28.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 143 | 204 | $38,717 | $11,668 | 30.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 46 | 46 | $24,428 | $6,557 | 26.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 92 | 95 | $9,798 | $2,937 | 30.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 112 | 130 | $8,830 | $2,669 | 30.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 25 | 26 | $7,323 | $2,228 | 30.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $7,231 | $2,184 | 30.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 26 | 26 | $4,995 | $1,522 | 30.5% |
About Dr. Dogan Temizer, M.D
Dr. Dogan Temizer, M.D is a Specialist healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407847031.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dogan Temizer, M.D has received a total of $3,273 in payments from pharmaceutical and medical device companies, with $425.65 received in 2019. These payments were reported across 192 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,266).
As a Medicare-enrolled provider, Temizer has provided services to 15,261 Medicare beneficiaries, totaling 18,463 services with total Medicare billing of $524,648. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Interventional Cardiology
- Location Cincinnati, OH
- Active Since 11/02/2005
- Last Updated 03/27/2012
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1407847031
Products in Payments
- ENTRESTO (Drug) $479.50
- XARELTO (Drug) $325.63
- GENERAL - STENTS (Device) $305.16
- ELIQUIS (Drug) $206.70
- Viva (Device) $172.01
- PRALUENT ALIROCUMAB INJECTION (Biological) $171.84
- Resolute (Device) $155.61
- Impella (Device) $149.47
- GENERAL STENTS (Device) $134.25
- CenterCross/Microcross/Multicross (Device) $125.00
- PRADAXA (Drug) $111.34
- LifeVest (Device) $86.85
- BRILINTA (Drug) $68.89
- Corlanor (Drug) $58.28
- ZONTIVITY (Drug) $53.88
- CoreValve Evolut (Device) $43.96
- Vascepa (Drug) $38.09
- PCI Optimization (Device) $37.36
- GENERAL - THERAPIES (Device) $37.27
- ILAB ULTRASOUND IMAGING SYSTEM (Device) $35.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Cincinnati
Gregory Gottschlich, Md, MD
Specialist — Payments: $40,331
Dr. Sasidhar Kilaru, M.d, M.D
Specialist — Payments: $37,347
Dr. Sadia Benzaquen, Md, MD
Specialist — Payments: $32,887
Mr. Michael Justin, M.d, M.D
Specialist — Payments: $31,478
Dr. Peter Stern, M.d, M.D
Specialist — Payments: $25,597
Peter Mckenna, M.d, M.D
Specialist — Payments: $15,168